Lexaria Bioscience Corp.

Lexaria Bioscience Corp. is a biotechnology company specializing in drug delivery technology. Its patented DehydraTECH enhances the oral delivery of active pharmaceutical ingredients, significantly increasing bio-absorption and reducing onset time. The technology is applicable to cannabinoids, nicotine, anti-viral drugs, NSAIDs, PDE5 inhibitors, and more. With 23 patents granted and approximately 50 patents pending globally, the company operates a licensed in-house research laboratory. By licensing its technology and intellectual property, Lexaria Bioscience generates revenue from pharmaceutical and biotech companies seeking to improve the effectiveness of their drug delivery methods.